Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT03249519

Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer

Led by University of Erlangen-Nürnberg Medical School · Updated on 2017-08-15

999

Participants Needed

1

Research Sites

4300 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The combination of radiation therapy or chemoradiation with Interstitial brachytherapy for advanced cervical cancer (pN+, FIGO-Stage II B - IV A is standard of therapy. The radio- and chemosensitive effect of an additional hyperthermia might improve the clinical outcome.

CONDITIONS

Official Title

Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically confirmed cervical carcinoma
  • Cervical cancer stage IIB to IVA, or earlier stages if inoperable or per patient's choice
  • No distant metastases except possible para-aortic lymph node involvement
  • Age 18 years or older
  • ECOG performance status 2 or less
  • Patient has given informed consent
Not Eligible

You will not qualify if you...

  • Uncontrolled cardiac disease or heart failure
  • Presence of a cardiac pacemaker
  • Myocardial infarction within the last 12 months
  • Congestive heart failure
  • Complete bundle branch block
  • NYHA class III or IV heart disease
  • Conditions preventing chemoradiation or deep regional hyperthermia
  • Metal implants longer than 2 cm or dense pelvic marker clips
  • Active or resistant bladder infections
  • Existing or concurrent immunodeficiency syndrome
  • Pregnant or breastfeeding women
  • Unwillingness to use effective contraception during and 6 months after therapy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Universitätsklinikum Erlangen, Strahlenklinik

Erlangen, Germany, 91054

Actively Recruiting

Loading map...

Research Team

O

Oliver Ott, MD

CONTACT

R

Rainer Fietkau, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer | DecenTrialz